Skip to main content
Premium Trial:

Request an Annual Quote

Cronus Distributing PamGene Technology in UK, Ireland

NEW YORK (GenomeWeb News) – Cronus Technologies has inked a distribution deal with PamGene International covering the UK and Ireland.

The deal, the terms of which were not disclosed, calls for UK-based Cronus to sell and market the PamStation 12 and PamChip microarrays. The PamStation 12 is a fully automated instrument for processing PamChip microarrays that provides real-time measurement of peptide phosphorylation by protein kinases in any sample type.

According to Cronus, the technology allows researchers to analyze kinase activity rather than presence "which is crucial to elucidate new signal transduction pathways, develop novel drug targets, and test kinase inhibitors." Additionally, it can also be used to develop algorithms for patient prognosis and prediction of response to treatments.

PamGene Managing Director Tim Kievets said that in addition to growing the network of PamGene users, the deal will allow his firm to develop more applications for the technology.

Based in The Netherlands, PamGene develops technology and applications for measuring cellular kinase activity and nuclear receptor activity.

Cronus distributes technologies for the cell and molecular biology market. In February, it and Axela signed a distribution deal covering Axela's instruments in the UK and Ireland.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.